Relationship between initial clinical presentation and the molecular cytogenetic classification of myeloma.
about
Salvage therapies in relapsed and/or refractory myeloma: what is current and what is the future?Interpretation of cytogenetic results in multiple myeloma for clinical practiceRole of osteocytes in multiple myeloma bone diseaseRacial differences in primary cytogenetic abnormalities in multiple myeloma: a multi-center study.Characteristics of exceptional responders to lenalidomide-based therapy in multiple myeloma.Myeloma today: Disease definitions and treatment advances.Bidirectional Notch Signaling and Osteocyte-Derived Factors in the Bone Marrow Microenvironment Promote Tumor Cell Proliferation and Bone Destruction in Multiple MyelomaBone marrow stromal cells show distinct gene expression patterns depending on symptomatically involved organs in multiple myeloma.Mechanisms of osteolytic and osteoblastic skeletal lesions.Role and mechanism of action of sclerostin in bone.Current Review on High-Risk Multiple Myeloma.Enzymatic activities of circulating plasma proteasomes in newly diagnosed multiple myeloma patients treated with carfilzomib, lenalidomide and dexamethasone.The role of initial clinical presentation, comorbidity and treatment in multiple myeloma patients on survival: a detailed population-based cohort study.Osteolytic lesions, cytogenetic features and bone marrow levels of cytokines and chemokines in multiple myeloma patients: Role of chemokine (C-C motif) ligand 20.Challenges and Promises of Genetic Stratification of Risk in Multiple Myeloma.Cancer Metastases to Bone: Concepts, Mechanisms, and Interactions with Bone Osteoblasts.Advanced Imaging of Multiple Myeloma Bone Disease
P2860
Q26740359-B4B827C4-1072-4617-837A-798392AB7EFAQ26777803-CA923B6B-E8A6-4018-990C-39FC121FF22FQ26992195-5C190987-1F41-45FF-A565-3D04D6746E31Q33600826-802FFF33-0994-4FE2-83AF-5E4A348329F8Q36254255-3BC0885F-40DF-4C4F-A76A-89C81A4DD6AAQ36470699-82BFA8F9-8B62-4E4C-B350-1DE32217CE74Q36642956-C8766525-8220-40E6-9AC9-580499285493Q37325029-897480BD-B841-4831-BD9D-CEBF493E9842Q38625793-272665A9-1266-41C9-BACB-26A79E0BED48Q38807230-B27234FD-9028-4DB0-B873-F390F798E594Q38895167-3B2604F0-166E-4A6D-9949-05D44CC3DCB4Q39336938-3B37912D-1652-4C96-9B46-3D593C9287F2Q40309114-0F991777-7B77-432A-9395-6FA8D65489D9Q40485837-53DC2B1A-08D5-4C67-9105-7F151B3A9B5EQ50319298-834D3A07-F085-4272-8EFE-17760D04E7D3Q55474543-3AA02416-FBB9-4099-8E46-027942325FAAQ57643732-7F0570F3-8591-4FBC-9129-B8D62C677461
P2860
Relationship between initial clinical presentation and the molecular cytogenetic classification of myeloma.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 05 September 2013
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Relationship between initial c ...... tic classification of myeloma.
@en
Relationship between initial c ...... tic classification of myeloma.
@nl
type
label
Relationship between initial c ...... tic classification of myeloma.
@en
Relationship between initial c ...... tic classification of myeloma.
@nl
prefLabel
Relationship between initial c ...... tic classification of myeloma.
@en
Relationship between initial c ...... tic classification of myeloma.
@nl
P2093
P2860
P356
P1433
P1476
Relationship between initial c ...... etic classification of myeloma
@en
P2093
A J Greenberg
T M Therneau
P2860
P2888
P304
P356
10.1038/LEU.2013.258
P577
2013-09-05T00:00:00Z